These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6350486)

  • 1. Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
    Brook I; Coolbaugh JC; Walker RI
    J Infect Dis; 1983 Jul; 148(1):156-9. PubMed ID: 6350486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
    Beale AS; Gisby J; Sutherland R
    J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of prophylactic antibiotics upon mixed infections with Bacteroides fragilis.
    Brook I
    Surg Gynecol Obstet; 1987 Dec; 165(6):491-5. PubMed ID: 3317944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    Can J Microbiol; 1984 Jan; 30(1):98-104. PubMed ID: 6143608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
    Bansal MB; Chuah SK; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
    Beale AS; Gisby J
    Infection; 1991; 19(2):101-5. PubMed ID: 2050417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
    Gisby J; Beale AS
    Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
    Brook I; Ledney GD
    J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
    Beale AS; Gisby J
    J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between Fusobacterium species and other flora in mixed infection.
    Brook I; Walker RI
    J Med Microbiol; 1986 Mar; 21(2):93-100. PubMed ID: 2936888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antimicrobial therapy on mixed infections with Bacteroides species. Is eradication of the anaerobes important?
    Brook I
    J Infect; 1991 Jan; 22(1):27-35. PubMed ID: 2002230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
    Brook I
    Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous metronidazole therapy for Bacteroides fragilis meningitis.
    Bryan CS; Huffman LJ; Del Bene VE; Sanders CV; Scalcini MC
    South Med J; 1979 Apr; 72(4):494-7. PubMed ID: 373128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metronidazole and spiramycin in abscesses caused by Bacteroides spp. and Staphylococcus aureus in mice.
    Brook I
    J Antimicrob Chemother; 1987 Nov; 20(5):713-8. PubMed ID: 3429373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.